How Much Does Low-Dose Naltrexone Cost in South Dakota in 2026?

What LDN Actually Costs in South Dakota Right Now

The average cash-pay price for low-dose naltrexone across South Dakota retail and compounding pharmacies in 2026 is $50 per month. That price applies to a standard 30-day supply of compounded oral capsules, typically dosed between 1.5 mg and 4.5 mg taken once nightly.

LDN is not manufactured by any pharmaceutical company at low doses. The FDA-approved formulation of naltrexone is a 50 mg tablet indicated for opioid and alcohol use disorders. Because LDN requires doses roughly 10 to 30 times lower than that approved tablet, patients must obtain their medication from a compounding pharmacy that can prepare custom-strength capsules. This compounding step is the primary driver of both cost and access considerations for South Dakota patients.

Prices can vary by $10 to $20 between compounding pharmacies depending on whether the pharmacy is local, out-of-state (shipping via mail order), or affiliated with a telehealth platform. Some telehealth providers bundle the prescription consultation fee and a 90-day supply for $120 to $180, which can reduce the effective monthly cost below $50. Patients should confirm that any out-of-state pharmacy holds a valid 503A license and is registered to ship into South Dakota before placing an order [1].

Why LDN Is Compounded and What 503A Means

LDN must be compounded because no FDA-approved product exists at the 1.5 mg to 4.5 mg dose range. Compounding is legal in every U.S. State under section 503A of the Federal Food, Drug, and Cosmetic Act.

A 503A pharmacy compounds medications on a patient-specific basis after receiving an individual prescription from a licensed prescriber. South Dakota permits 503A compounding pharmacies to operate within state borders and allows residents to receive compounded medications from out-of-state 503A pharmacies, provided those pharmacies comply with both their home state's Board of Pharmacy regulations and federal compounding law. The South Dakota Board of Pharmacy does not maintain a separate "compounded drug" formulary restriction, meaning that a valid prescription from a licensed provider is sufficient for a 503A pharmacy to compound LDN [2].

For context, the distinction matters because 503B outsourcing facilities (a separate FDA category) compound without individual prescriptions and operate under stricter federal oversight. Most patients obtaining LDN will interact with 503A pharmacies, whether local or via mail order. The practical result for South Dakota residents: you need a prescription, and any licensed 503A pharmacy can fill it.

South Dakota Medicaid and LDN Coverage

South Dakota Medicaid does not cover low-dose naltrexone for off-label indications such as fibromyalgia, chronic pain, or autoimmune conditions. This is consistent with most state Medicaid programs nationwide.

The core issue is the FDA approval gap. Naltrexone carries FDA approval only at 50 mg for opioid use disorder and alcohol dependence. When a drug is used off-label, Medicaid programs have broad discretion to deny coverage, and South Dakota's Medicaid preferred drug list does not include compounded naltrexone at low doses. A Younger et al. Pilot study (N=10) published in Pain Medicine demonstrated that LDN at 4.5 mg reduced fibromyalgia symptoms by 30% compared to placebo, but this small trial has not generated the level of evidence state Medicaid formulary committees typically require for coverage decisions [3].

Patients enrolled in South Dakota Medicaid who want to try LDN will need to pay cash. At $50 per month, LDN remains one of the more affordable specialty medications available even without insurance. Some compounding pharmacies offer discount programs or multi-month pricing that can bring per-month costs below $40 (see the savings section below).

Commercial Insurance Coverage in South Dakota

Most commercial insurance plans in South Dakota do not cover compounded LDN. The reasons overlap with Medicaid: off-label use, lack of a commercially manufactured low-dose product, and absence of large-scale Phase III trial data.

A small number of plans may cover generic naltrexone 50 mg tablets, which some patients split or dissolve to approximate a low dose. This approach is not recommended by most prescribers because naltrexone tablets are not scored for accurate splitting at the 1.5 to 4.5 mg range, and dissolution methods produce inconsistent dosing. The cost of generic 50 mg naltrexone with insurance is often $10 to $25 per month, but the dosing imprecision makes it a poor substitute for properly compounded capsules.

If you carry a commercial plan through Avera, Sanford Health Plan, or a national carrier (Blue Cross Blue Shield, UnitedHealthcare, Aetna), you can submit a prior authorization request. Approval rates are low. Most patients who successfully obtain insurance coverage for LDN do so through appeals that include a letter of medical necessity from their prescriber, documentation of failed first-line therapies, and supporting literature. Even then, the insurer may cover the 50 mg generic tablet rather than the compounded formulation.

For the majority of South Dakota patients, cash pay at a compounding pharmacy is faster and more predictable than pursuing insurance coverage.

Telehealth Prescribing: How SD Residents Access LDN

South Dakota permits telehealth prescribing of low-dose naltrexone. A provider licensed in South Dakota (or holding an appropriate multi-state license) can evaluate a patient via video or audio consultation and write a prescription for compounded LDN without an in-person visit.

This matters because South Dakota is a large, rural state. Sioux Falls and Rapid City have compounding pharmacies, but patients in western or central SD may live hours from the nearest one. Telehealth solves two problems at once: it connects patients with prescribers experienced in LDN therapy (a subset of providers, since LDN remains off-label), and it pairs that prescription with a mail-order 503A pharmacy that ships directly to the patient's address.

Several national telehealth platforms now offer LDN consultations. Consultation fees typically range from $50 to $150 for an initial visit, with follow-up appointments at $30 to $75. Some platforms bundle the consultation and a 90-day medication supply into a single price between $120 and $180. South Dakota does not impose additional restrictions on telehealth-prescribed compounded medications beyond the standard requirement that the prescriber hold a valid license [4].

Patients should verify two things before using a telehealth LDN service: (1) the prescribing provider is licensed to practice in South Dakota, and (2) the compounding pharmacy holds a valid 503A license. Both can be confirmed through the South Dakota Board of Medical and Osteopathic Examiners and the South Dakota Board of Pharmacy, respectively.

LDN Pricing Compared to Other States

South Dakota's $50/month average cash-pay price for compounded LDN sits near the national median. Prices across the U.S. Generally range from $30 to $90 per month depending on the pharmacy, geographic region, and whether the patient uses a telehealth bundle.

States with large compounding pharmacy markets (Florida, Texas, California) tend to have slightly lower prices due to competition. South Dakota's pricing reflects a smaller in-state compounding pharmacy market offset by easy access to national mail-order 503A pharmacies. The net effect is pricing that tracks the national average closely.

One factor that can push costs higher in SD is shipping. Some mail-order pharmacies charge $5 to $10 for shipping per order. Ordering a 90-day supply instead of a 30-day supply typically eliminates or reduces this per-month shipping overhead. A 90-day supply from most compounding pharmacies runs $120 to $140, bringing the effective monthly cost to $40 to $47 before shipping.

How to Reduce Your LDN Costs in South Dakota

Several strategies can bring the out-of-pocket cost below the $50/month average.

Order in 90-day quantities. Most compounding pharmacies offer a per-unit discount on larger fills. A 90-day supply commonly costs $120 to $140 versus $150 for three separate monthly fills.

Compare multiple 503A pharmacies. Prices vary. Request quotes from at least two or three pharmacies, including both in-state options (Sioux Falls and Rapid City have compounding pharmacies) and national mail-order 503A pharmacies. Some pharmacies list LDN pricing directly on their websites.

Use a telehealth bundle. Certain telehealth platforms that specialize in LDN prescribing negotiate volume pricing with their partner compounding pharmacies. The combined consultation-plus-medication price can be lower than paying for each separately.

Ask about loyalty or subscription programs. A growing number of compounding pharmacies offer monthly subscription pricing for LDN patients, locking in a rate of $35 to $45/month with automatic refills. These programs sometimes include free shipping.

Check patient assistance foundations. While no manufacturer assistance program exists for LDN (since there is no manufacturer), some nonprofit organizations focused on chronic pain and autoimmune conditions offer small grants or subsidies to help patients afford compounded medications. The LDN Research Trust, based in the UK but serving patients globally, maintains a directory of resources [5].

Standard pharmacy discount cards (GoodRx, RxSaver) generally do not apply to compounded medications. These cards negotiate discounts with retail pharmacies on commercially manufactured drugs and are not structured for 503A compounding orders.

What the Clinical Evidence Says About LDN

LDN's off-label use is supported by a growing but still limited body of clinical evidence, which directly affects both insurance coverage decisions and prescriber willingness.

The most frequently cited early study is the Younger et al. 2009 pilot crossover trial in Pain Medicine. Ten women with fibromyalgia received LDN 4.5 mg nightly for 8 weeks versus placebo. LDN reduced daily pain scores by 32.5% compared to baseline, exceeding the placebo response. The same research group followed up with a larger single-blind study (N=31) in 2013 confirming a 28.8% reduction in pain severity [3][6].

For Crohn's disease, a Smith et al. Randomized controlled trial (N=40) published in the Journal of Clinical Gastroenterology found that 4.5 mg LDN produced an 89% response rate versus 40% for placebo at 12 weeks, measured by a 70-point decrease in Crohn's Disease Activity Index [7]. An earlier open-label pilot (N=17) by the same group showed endoscopic healing in 33% of participants [8].

A 2022 retrospective cohort study published in JAMA Network Open examined naltrexone prescriptions across a large U.S. Claims database and found that off-label low-dose prescribing increased 215% between 2015 and 2020, reflecting growing clinician interest despite the absence of Phase III registration trials [9].

These studies support LDN as a plausible therapeutic option but do not meet the evidence threshold that most formulary committees, including South Dakota Medicaid's, require for coverage approval. Large, multicenter, Phase III randomized controlled trials are still lacking.

Choosing a Compounding Pharmacy in South Dakota

South Dakota residents have two main pathways to a compounding pharmacy: in-state brick-and-mortar pharmacies and out-of-state mail-order 503A pharmacies.

In-state options. Compounding pharmacies in Sioux Falls and Rapid City can fill LDN prescriptions. Patients can call ahead to confirm that the pharmacy compounds naltrexone at low doses, as not all compounding pharmacies stock every medication. The South Dakota Board of Pharmacy maintains a registry of licensed pharmacies, though it does not separately flag compounding capability.

Mail-order 503A pharmacies. National compounding pharmacies licensed under section 503A can ship compounded LDN to South Dakota addresses. These pharmacies are often based in states with large compounding markets (Florida, Arizona, Texas). Before using an out-of-state pharmacy, verify that it holds a valid, non-restricted 503A license and that it is registered or otherwise authorized to ship into South Dakota. Your prescriber's office can often help identify reputable options.

Red flags to watch for. Avoid any pharmacy that offers LDN without a prescription, claims to sell "research-grade" naltrexone for human use, or cannot provide documentation of its 503A license. LDN is a prescription-only compounded medication, and bypassing the prescription requirement violates federal and state law.

What to Expect When Starting LDN in South Dakota

Prescribers typically begin LDN at 1.5 mg nightly and titrate upward by 0.5 mg to 1.5 mg increments every one to two weeks until reaching the target dose of 3 mg to 4.5 mg. This gradual titration minimizes early side effects, most commonly vivid dreams, mild headache, and transient nausea. Most side effects resolve within the first two to four weeks [3].

Because LDN is prescribed off-label, South Dakota providers may want baseline labs (complete blood count, liver function tests) before initiating therapy, particularly if the patient has a history of hepatic impairment. The FDA label for naltrexone 50 mg includes a boxed warning about hepatotoxicity at doses of 300 mg/day (observed in early obesity trials), but doses at 1.5 to 4.5 mg are roughly 1/10th to 1/33rd of the standard 50 mg dose, and no cases of LDN-related hepatotoxicity have been reported in published literature [1][3].

Patients taking opioid medications cannot use LDN. Naltrexone is an opioid receptor antagonist, and even at low doses it can precipitate withdrawal in opioid-dependent individuals. Prescribers will confirm opioid-free status before writing an LDN prescription. A minimum washout period of 7 to 10 days from short-acting opioids (or 10 to 14 days from long-acting opioids) is standard practice.

Follow-up appointments every 4 to 8 weeks during dose titration allow the prescriber to assess symptom response and tolerability. Once a stable dose is reached, follow-up frequency typically decreases to every 3 to 6 months.